The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
Background: MS is a highly heterogeneous disease, both in its course and in its response to treatments. Effective biomarkers may help predict disability progression and monitor patients’ treatment responses. <br/>Objective: To focus on how biomarkers may contribute to treatment individualisat...
主要な著者: | Vermersch, P, Berger, T, Gold, R, Lukas, C, Rovira, A, Meesen, B, Chard, D, Comabella, M, Palace, J, Trojano, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
SAGE Publications
2016
|
類似資料
-
Personalised CLIP or: how to find your vacation videos
著者:: Korbar, B, 等
出版事項: (2022) -
How personalised medicine will transform healthcare by 2030: the ICPerMed vision
著者:: Astrid M. Vicente, 等
出版事項: (2020-04-01) -
Sleep apnoea syndrome: how will physiologic knowledge position personalised medicine?
著者:: F. Sériès
出版事項: (2011-09-01) -
Biomarkers in Psoriasis: The Future of Personalised Treatment
著者:: Bikash R. Kar, 等
出版事項: (2024-06-01) -
How the Turn to Practice may Contribute to Working Life Studies
著者:: Silvia Gherardi
出版事項: (2015-11-01)